S. O'brien

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

D. Nutt, B. Sessa, C. Sakal, 2019, BMJ Case Reports.

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder

D. Nutt, Sue J. Wilson, T. Williams, 2021, Journal of psychopharmacology.

Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA

Jacob S. Aday, D. Nutt, H. Curran, 2021, Journal of psychopharmacology.